Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications.

Glycerophospholipids containing arachidonic acid (20:4) serve as the precursors for an array of biologically active lipid mediators, most of which are produced by macrophages. We have applied mass spectrometry-based lipid profiling technology to evaluate the glycerophospholipid structure and composition of two macrophage populations, resident peritoneal macrophages and RAW264.7 cells, with regard to their potential for 20:4-based lipid mediator biosynthesis. Fatty acid analysis indicated that RAW264.7 cells were deficient in 20:4 (10 +/- 1 mol %) compared to peritoneal macrophages (26 +/- 1 mol %). Mass spectrometry of total glycerophospholipids demonstrated a marked difference in the distribution of lipid species, including reduced levels of 20:4-containing lipids, in RAW264.7 cells compared to peritoneal macrophages. Enrichment of RAW264.7 cells with 20:4 increased the fatty acid to 20 +/- 1 mol %. However, the distribution of the incorporated 20:4 remained different from that of peritoneal macrophages. RAW264.7 cells pretreated with granulocyte-macrophage colony stimulating factor followed by lipopolysaccharide and interferon-gamma mobilized similar quantities of 20:4 and produced similar amounts of prostaglandins as peritoneal macrophages treated with LPS alone. LPS treatment resulted in detectable changes in specific 20:4-containing glycerophospholipids in peritoneal cells, but not in RAW264.7 cells. 20:4-enriched RAW264.7 cells lost 88% of the incorporated fatty acid during the LPS incubation without additional prostaglandin synthesis. These results illustrate that large differences in glycerophospholipid composition may exist, even in closely related cell populations, and demonstrate the importance of interpreting the potential for lipid-mediator biosynthesis in the context of overall glycerophospholipid composition.

[1]  Jeffrey S. Forrester,et al.  Lipidomics: an analysis of cellular lipids by ESI-MS. , 2006, Methods.

[2]  Meenakshi Rani,et al.  GM-CSF priming of human monocytes is dependent on ERK1/2 activation , 2006, Journal of endotoxin research.

[3]  M. Linton,et al.  Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes. , 2005, Metabolism: clinical and experimental.

[4]  L. Marnett,et al.  Simultaneous analysis of prostaglandin glyceryl esters and prostaglandins by electrospray tandem mass spectrometry. , 2005, Analytical biochemistry.

[5]  Lawrence J Marnett,et al.  Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus* , 2005, Journal of Biological Chemistry.

[6]  J. Morrow,et al.  RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-α secretion Published, JLR Papers in Press, February 1, 2005. DOI 10.1194/jlr.M500006-JLR200 , 2005, Journal of Lipid Research.

[7]  Lawrence J. Marnett,et al.  Cyclooxygenase-1-dependent Prostaglandin Synthesis Modulates Tumor Necrosis Factor-α Secretion in Lipopolysaccharide-challenged Murine Resident Peritoneal Macrophages* , 2004, Journal of Biological Chemistry.

[8]  H. Brown,et al.  Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. , 2004, Molecular pharmacology.

[9]  F. McLafferty,et al.  Electrospray ionization mass spectrometry analysis of changes in phospholipids in RBL-2H3 mastocytoma cells during degranulation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Wan-Wan Lin,et al.  Ceramide Inhibits Lipopolysaccharide-Mediated Nitric Oxide Synthase and Cyclooxygenase-2 Induction in Macrophages: Effects on Protein Kinases and Transcription Factors1 , 2001, The Journal of Immunology.

[11]  Takao Shimizu,et al.  Localization and regulation of cytosolic phospholipase A(2). , 2000, Biochimica et biophysica acta.

[12]  A. Descoteaux,et al.  Cyclooxygenase-2 Expression in Macrophages: Modulation by Protein Kinase C-α1 , 2000, The Journal of Immunology.

[13]  C. Hillard Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. , 2000, Prostaglandins & other lipid mediators.

[14]  S. Ghosh,et al.  Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages* , 2000, The Journal of Biological Chemistry.

[15]  K. Austen,et al.  Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Kniss,et al.  Blockade of nitric oxide formation down‐regulates cyclooxygenase‐2 and decreases PGE2 biosynthesis in macrophages , 1999, Journal of leukocyte biology.

[17]  R. Zoeller,et al.  Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. , 1999, Journal of lipid research.

[18]  C. Leslie,et al.  Regulation of arachidonic acid release and cytosolic Phospholipase A2 activation , 1999, Journal of leukocyte biology.

[19]  G. Yu,et al.  Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. , 1997, Biochemical pharmacology.

[20]  W. Lehmann,et al.  Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Y. Nakagawa,et al.  Changes in arachidonic acid metabolism and the aggregation of polymorphonuclear leukocytes in rats with streptozotocin-induced diabetes. , 1996, Biochimica et biophysica acta.

[22]  P. Lesnik,et al.  Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. , 1996, European journal of biochemistry.

[23]  K. Chadee,et al.  Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. , 1995, Biochemical and biophysical research communications.

[24]  G. Zimmerman,et al.  Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. , 1989, The Journal of biological chemistry.

[25]  F. Chilton,et al.  1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil. , 1988, The Journal of biological chemistry.

[26]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[27]  Nakagawa Yasuhito,et al.  Relative degradation of different arachidonoyl molecular species of choline glycerophospholipids in opsonized zymosan-stimulated rabbit alveolar macrophages. , 1986 .

[28]  K. Fukushima,et al.  The stimulation of macrophage prostaglandin E2 and thromboxane B2 secretion by Streptococcus mutans insoluble glucans , 1983, FEBS letters.

[29]  D. Katz,et al.  IgE immune complexes stimulate arachidonic acid release by mouse peritoneal macrophages. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Murray,et al.  Regulation of arachidonic acid metabolism by macrophage activation , 1982, The Journal of experimental medicine.

[31]  F. Wigley,et al.  Neutral protease activation of peritoneal macrophage prostaglandin synthesis. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Z. Cohn,et al.  Regulation of arachidonic acid metabolites in macrophages , 1980, The Journal of experimental medicine.

[33]  C. Rouzer,et al.  Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Z. Cohn,et al.  Influence of fatty acyl substitution on the composition and function of macrophage membranes. , 1980, The Journal of biological chemistry.

[35]  M. Caton,et al.  Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.

[36]  P. Ralph,et al.  Functional macrophage cell lines transformed by abelson leukemia virus , 1978, Cell.

[37]  Z. Cohn,et al.  Response of endocytosis to altered fatty acyl composition of macrophage phospholipids. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. Kuehl,et al.  Macrophages synthesise and release prostaglandins in response to inflammatory stimuli , 1977, Nature.

[39]  T. Stossel,et al.  Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. , 1972, The Journal of clinical investigation.

[40]  J. Morrow,et al.  RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-alpha secretion. , 2005, Journal of lipid research.

[41]  A. Descoteaux,et al.  Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. , 2000, Journal of immunology.

[42]  G. Cryer,et al.  Regulation of macrophage eicosanoid generation is dependent on nuclear factor kappaB. , 1998, The Journal of trauma.

[43]  C. Pace-Asciak,et al.  Biosynthesis, catabolism, and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. , 1989, Free radical biology & medicine.

[44]  F. Snyder Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing. , 1988, Progress in clinical and biological research.

[45]  K. Waku,et al.  Relative degradation of different arachidonoyl molecular species of choline glycerophospholipids in opsonized zymosan-stimulated rabbit alveolar macrophages. , 1986, Biochimica et biophysica acta.

[46]  B. Samuelsson Prostaglandins and Thromboxanes , 1977, NATO Advanced Study Institutes Series.